Helius Medical Technologies Inc (HSDT)
1.51
-0.01
(-0.66%)
USD |
NASDAQ |
May 17, 16:00
1.51
0.00 (0.00%)
After-Hours: 20:00
Helius Medical Technologies Cash from Financing (Quarterly): 0.622M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.622M |
| September 30, 2023 | 0.455M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 17.25M |
| June 30, 2022 | 0.637M |
| March 31, 2022 | -0.017M |
| December 31, 2021 | 9.773M |
| September 30, 2021 | 0.519M |
| June 30, 2021 | -0.186M |
| March 31, 2021 | 11.02M |
| December 31, 2020 | 2.911M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 4.075M |
| March 31, 2020 | 2.652M |
| December 31, 2019 | 1.49M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.123M |
| March 31, 2019 | 0.04M |
| December 31, 2018 | 18.34M |
| Date | Value |
|---|---|
| September 30, 2018 | -0.02M |
| June 30, 2018 | 18.03M |
| March 31, 2018 | 3.68M |
| December 31, 2017 | 8.008M |
| September 30, 2017 | 0.451M |
| June 30, 2017 | 5.783M |
| March 31, 2017 | 7.976M |
| September 30, 2016 | 0.0963M |
| June 30, 2016 | 7.792M |
| March 31, 2016 | -0.0395M |
| December 31, 2015 | 6.840M |
| September 30, 2015 | 0.4967M |
| June 30, 2015 | 2.395M |
| March 31, 2015 | 0.2123M |
| December 31, 2014 | 0.0212M |
| September 30, 2014 | 0.0086M |
| June 30, 2014 | 7.241M |
| March 31, 2014 | 0.3376M |
| December 31, 2013 | 0.0099M |
| September 30, 2013 | 0.017M |
| June 30, 2013 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.186M
Minimum
Jun 2021
17.25M
Maximum
Sep 2022
2.701M
Average
0.519M
Median
Sep 2021
Cash from Financing (Quarterly) Benchmarks
| ARCA biopharma Inc | 0.00 |
| Integra Lifesciences Holdings Corp | 358.68M |
| NeuroOne Medical Technologies Corp | 1.205M |
| Perspective Therapeutics Inc | 0.352M |
| Electromed Inc | 0.056M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.034M |
| Cash from Investing (Quarterly) | -0.003M |
| Free Cash Flow | -10.44M |
| Free Cash Flow Per Share (Quarterly) | -2.870 |
| Free Cash Flow to Equity (Quarterly) | -2.037M |
| Free Cash Flow to Firm (Quarterly) | -2.037M |
| Free Cash Flow Yield | -1.10K% |